| scholarly article | Q13442814 |
| P50 | author | Patrik K E Magnusson | Q37389903 |
| Karolina Aberg | Q42823965 | ||
| Joseph L. McClay | Q47709495 | ||
| Patrick F. Sullivan | Q56249782 | ||
| Christina M. Hultman | Q65824971 | ||
| P2093 | author name string | Gaurav Kumar | |
| Edwin J C G van den Oord | |||
| Amit N Khachane | |||
| Guimin Gao | |||
| Wenan Chen | |||
| Srilaxmi Nerella | |||
| Linying Xie | |||
| Aki Harada | |||
| Alexandra Hudson | |||
| Shaunna Clark | |||
| P2860 | cites work | Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation | Q21194851 |
| The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression | Q21261456 | ||
| Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia | Q24530247 | ||
| Reelin promoter hypermethylation in schizophrenia | Q24531469 | ||
| Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder | Q24594904 | ||
| ConsensusPathDB: toward a more complete picture of cell biology | Q24611619 | ||
| Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder | Q24652360 | ||
| Epigenomic profiling reveals DNA-methylation changes associated with major psychosis | Q24655403 | ||
| A decrease of reelin expression as a putative vulnerability factor in schizophrenia | Q24657918 | ||
| Statistical significance for genomewide studies | Q24681264 | ||
| Current status and future prospects for epigenetic psychopharmacology | Q26825464 | ||
| Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing | Q28187734 | ||
| Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia | Q28236058 | ||
| Dynamic DNA methylation programs persistent adverse effects of early-life stress | Q28264120 | ||
| Reactome: a database of reactions, pathways and biological processes | Q28298042 | ||
| p300 expression is induced by oxygen deficiency and protects neuron cells from damage | Q28565377 | ||
| Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1) | Q28593204 | ||
| Epigenome-wide association studies for common human diseases | Q28710498 | ||
| Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder | Q28943293 | ||
| KEGG for integration and interpretation of large-scale molecular data sets | Q29547277 | ||
| Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study | Q29616193 | ||
| Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation | Q29619687 | ||
| Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. | Q30436442 | ||
| DNA methylation arrays as surrogate measures of cell mixture distribution | Q30530775 | ||
| FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies | Q30986287 | ||
| Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis | Q33333326 | ||
| Non-imprinted allele-specific DNA methylation on human autosomes. | Q33616901 | ||
| Allelic skewing of DNA methylation is widespread across the genome | Q33645884 | ||
| Evidence mining and novelty assessment of protein-protein interactions with the ConsensusPathDB plugin for Cytoscape | Q33694229 | ||
| LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors | Q33763848 | ||
| Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes | Q33862644 | ||
| Genetic architectures of psychiatric disorders: the emerging picture and its implications | Q33949729 | ||
| Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage | Q34153652 | ||
| Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report | Q34395443 | ||
| Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. | Q34536750 | ||
| Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis | Q34555143 | ||
| Estimation of CpG coverage in whole methylome next-generation sequencing studies | Q34582324 | ||
| MethylPCA: a toolkit to control for confounders in methylome-wide association studies | Q34604581 | ||
| Methylation status of the reelin promoter region in the brain of schizophrenic patients | Q34687723 | ||
| Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression | Q34770083 | ||
| Epigenetics and the Environment | Q35118498 | ||
| Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling | Q35216929 | ||
| The genetics of adult-onset neuropsychiatric disease: complexities and conundra? | Q35573426 | ||
| Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. | Q36676024 | ||
| Molecular studies of major depressive disorder: the epigenetic perspective | Q36786517 | ||
| The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia | Q36874705 | ||
| Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context | Q37283233 | ||
| Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions | Q37524743 | ||
| MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case--control samples | Q37581443 | ||
| DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. | Q38325560 | ||
| ConsensusPathDB--a database for integrating human functional interaction networks | Q38386413 | ||
| Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1α expression in human non-small cell lung cancer cells | Q39393739 | ||
| Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression | Q39584927 | ||
| Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset | Q39639670 | ||
| Quantitative comparison of genome-wide DNA methylation mapping technologies. | Q39654059 | ||
| MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome | Q39776070 | ||
| Parental imprinting of autosomal mammalian genes | Q40672445 | ||
| Epigenetics: Stress makes its molecular mark | Q41088347 | ||
| Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences | Q41827630 | ||
| Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation in mice | Q42660124 | ||
| Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? | Q44543032 | ||
| Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1 alpha and HIF-2 alpha in a primary neuronal model of hypoxia | Q48026234 | ||
| Epigenetic aberration of the human REELIN gene in psychiatric disorders | Q48268710 | ||
| DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder | Q48960452 | ||
| Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. | Q51035222 | ||
| Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia. | Q51373014 | ||
| Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. | Q51806549 | ||
| Schizophrenia | Q55868331 | ||
| The DNA methylation profile within the 5'-regulatory region of DRD2 in discordant sib pairs with schizophrenia | Q79508037 | ||
| Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation | Q81490137 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| biomarker | Q864574 | ||
| P304 | page(s) | 255-264 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults | |
| P478 | volume | 71 |
| Q58712902 | A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia |
| Q36994826 | A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q64122396 | A kernel machine method for detecting higher order interactions in multimodal datasets: Application to schizophrenia |
| Q90003008 | A methylation study of long-term depression risk |
| Q36379034 | A rare-variant test for high-dimensional data |
| Q44911943 | Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportions |
| Q38816605 | Advances in the genetics of schizophrenia: toward a network and pathway view for drug discovery |
| Q34530455 | Age-associated decrease in global DNA methylation in patients with major depression |
| Q40144036 | An epigenome-wide DNA methylation study of PTSD and depression in World Trade Center responders |
| Q37344769 | An epigenomics approach to individual differences and its translation to neuropsychiatric conditions |
| Q37216035 | An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation |
| Q38528430 | An update on the epigenetics of psychotic diseases and autism |
| Q92523805 | Analysis of the superior temporal gyrus as a possible biomarker in schizophrenia using voxel-based morphometry of the brain magnetic resonance imaging: a comprehensive review |
| Q36599271 | Annual Research Review: Discovery science strategies in studies of the pathophysiology of child and adolescent psychiatric disorders--promises and limitations |
| Q40630289 | Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. |
| Q39854190 | Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study. |
| Q35683741 | Association of DNA Methylation with Acute Mania and Inflammatory Markers |
| Q89675757 | Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function |
| Q26752612 | Biomarkers for drug development in early psychosis: Current issues and promising directions |
| Q28068871 | Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics |
| Q48130138 | Borderline personality disorder and childhood maltreatment: a genome-wide methylation analysis |
| Q40970457 | Candidate gene methylation studies are at high risk of erroneous conclusions |
| Q37626773 | Childhood maltreatment and stress-related psychopathology: the epigenetic memory hypothesis |
| Q90781310 | Chromatin profiling of cortical neurons identifies individual epigenetic signatures in schizophrenia |
| Q35889359 | Combined Whole Methylome and Genomewide Association Study Implicates CNTN4 in Alcohol Use |
| Q38805367 | Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms |
| Q41291393 | Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders |
| Q37615890 | Correcting for cell-type effects in DNA methylation studies: reference-based method outperforms latent variable approaches in empirical studies |
| Q36579945 | Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research |
| Q45001829 | Could monitoring methylation markers aid the management of schizophrenia? |
| Q38776934 | Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia |
| Q34802996 | Crucial timing in schizophrenia: role of DNA methylation in early neurodevelopment. |
| Q38750121 | D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity |
| Q39317377 | DNA Methylation in Schizophrenia |
| Q36176889 | DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain |
| Q33707704 | DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia |
| Q26996421 | DNA methylation biomarkers: cancer and beyond |
| Q35904256 | DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review |
| Q100515583 | DNA methylation methods: global DNA methylation and methylomic analyses |
| Q48263449 | DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients |
| Q38429254 | Differential DNA methylation at birth associated with mental disorder in individuals with 22q11.2 deletion syndrome |
| Q38589868 | Early life trauma, depression and the glucocorticoid receptor gene--an epigenetic perspective. |
| Q39016076 | Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman's Dynamic Legacy |
| Q33878718 | Enrichment methods provide a feasible approach to comprehensive and adequately powered investigations of the brain methylome |
| Q38602855 | Epigenetic Basis of Mental Illness |
| Q26752594 | Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders |
| Q33858861 | Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. |
| Q38873613 | Epigenetic mechanisms in neurogenesis |
| Q92453407 | Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings |
| Q34426222 | Epigenetic mechanisms in schizophrenia. |
| Q57798749 | Epigenetics in eating disorders: a systematic review |
| Q93063625 | Epigenome-wide association study of depression symptomatology in elderly monozygotic twins |
| Q37347848 | Epigenomic profiling of preterm infants reveals DNA methylation differences at sites associated with neural function |
| Q47649569 | Ethical Application of Precision Medicine to Schizophrenia Management. |
| Q35692533 | Evaluation of Methyl-Binding Domain Based Enrichment Approaches Revisited |
| Q58797763 | Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia |
| Q38714222 | Expression and regulation of human endogenous retrovirus W elements. |
| Q38286470 | Fetal programming of schizophrenia: select mechanisms |
| Q90294273 | From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies |
| Q35046123 | GWAS, cytomegalovirus infection, and schizophrenia. |
| Q99616604 | Gene co-expression networks in peripheral blood capture dimensional measures of emotional and behavioral problems from the Child Behavior Checklist (CBCL) |
| Q41144061 | Genetic and epigenetic analysis of schizophrenia in blood-a no-brainer? |
| Q104079518 | Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population |
| Q41314364 | Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder. |
| Q38262765 | Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back. |
| Q58767549 | Glioma in Schizophrenia: Is the Risk Higher or Lower? |
| Q37581401 | Global methylation status of sperm DNA in carriers of chromosome structural aberrations. |
| Q36424823 | High density methylation QTL analysis in human blood via next-generation sequencing of the methylated genomic DNA fraction |
| Q35177686 | Horizons of psychiatric genetics and epigenetics: where are we and where are we heading? |
| Q36895666 | Hypomethylation of FAM63B in bipolar disorder patients. |
| Q42052561 | Insights into psychosis risk from leukocyte microRNA expression |
| Q31049198 | Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases |
| Q36055182 | Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia. |
| Q90705868 | LncRNA-AWPPH activates TGF-β1 in colorectal adenocarcinoma |
| Q61801098 | Longitudinal investigation of DNA methylation changes preceding adolescent psychotic experiences |
| Q38219909 | Making sense of deep sequencing |
| Q38259759 | Maternal immune activation and abnormal brain development across CNS disorders. |
| Q89183179 | Mega-analysis of Odds Ratio: A Convergent Method for a Deep Understanding of the Genetic Evidence in Schizophrenia |
| Q46623644 | Methyl-CpG-Binding Domain Sequencing: MBD-seq |
| Q64916433 | Methylation analysis for postpartum depression: a case control study. |
| Q36903458 | Methylomic analysis of monozygotic twins discordant for childhood psychotic symptoms. |
| Q38971174 | Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2. |
| Q37736142 | Methylomic changes during conversion to psychosis. |
| Q33562662 | Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol |
| Q34676602 | Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia |
| Q58744139 | Newborn blood DNA epigenetic variations and signaling pathway genes associated with Tetralogy of Fallot (TOF) |
| Q36509778 | Non-CG Methylation in the Human Genome. |
| Q37200180 | Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder. |
| Q57796559 | Prediction of smoking by multiplex bisulfite PCR with long amplicons considering allele-specific effects on DNA methylation |
| Q55433966 | Prenatal immune activation alters the adult neural epigenome but can be partly stabilised by a n-3 polyunsaturated fatty acid diet. |
| Q30857458 | Refinement of schizophrenia GWAS loci using methylome-wide association data |
| Q38991585 | Response to: Correcting for cell-type effects in DNA methylation studies: reference-based method outperforms latent variable approaches in empirical studies. |
| Q39566363 | SZDB: A Database for Schizophrenia Genetic Research |
| Q36063627 | Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia |
| Q90600553 | The Epigenetic Basis of Individuality |
| Q37724137 | The Epigenetic Link between Prenatal Adverse Environments and Neurodevelopmental Disorders |
| Q35927955 | The contribution of protein intrinsic disorder to understand the role of genetic variants uncovered by autism spectrum disorders exome studies. |
| Q38189293 | The epigenome and postnatal environmental influences in psychotic disorders. |
| Q26774674 | The impact of next-generation sequencing on the DNA methylation-based translational cancer research |
| Q38872287 | The role of DNA methylation in the pathophysiology and treatment of bipolar disorder. |
| Q49584264 | The role of epigenomics in personalized medicine. |
| Q64882078 | Untargeted metabolomics reveals multiple metabolites influencing smoking-related DNA methylation. |
| Q52585640 | [Genetics and epigenetics of schizophrenia and other psychoses]. |
Search more.